Acuta Capital Partners’s Vincerx Pharma, Inc. Warrant VINCW Stock Holding History

Acuta Capital Partners’s Portfolio VINCW Stock Details VINCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-520,000	Closed	-$2.1M	–	52
2021 Q1	$2.1M	Buy	+520,000	New	+$2.11M	0.76%	35

Acuta Capital Partners's VINCW Position: Q2 2021 in Review

Acuta Capital Partners sold out of Vincerx Pharma, Inc. Warrant (VINCW) in Q2 2021, closing a stake of 520,000 shares — an estimated $2.1M sold.

Acuta Capital Partners first reported a position in VINCW in Q1 2021 and held it in 1 quarter. The position peaked at $2.1M in Q1 2021. 0 funds tracked by Wall St. Rank hold VINCW as of Q2 2021.

Acuta Capital Partners reported no remaining Vincerx Pharma, Inc. Warrant position as of Q2 2021 after selling out during the quarter.
Acuta Capital Partners sold 520,000 Vincerx Pharma, Inc. Warrant shares in Q2 2021, an estimated $2.1M.
Acuta Capital Partners first reported a position in Vincerx Pharma, Inc. Warrant in Q1 2021 and held it in 1 quarter.
Acuta Capital Partners's Vincerx Pharma, Inc. Warrant position peaked at $2.1M in Q1 2021.
0 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Warrant as of Q2 2021.

Based on Acuta Capital Partners's 13F filing for Q2 2021, filed 16 Aug 2021.